Introduction
Diabetes mellitus has been associated with cardiac disease that has been suggested to occur secondary to atherosclerosis of the coronary arteries, macroangiopathy and w x autonomic neuropathy 1 . However, a cardiac disease particular to diabetes has also been demonstrated to occur in the absence of the above factors. This 'diabetic cardiomyopathy' that includes cardiomegaly, left ventricular dysfunction and clinically overt congestive heart failure has been strongly suggested by epidemiological, clinical w x and experimental studies 2-7 . The etiology of diabetic cardiomyopathy is complex and a number of factors have been suggested to be involved in the development of this Ž . disease state. These include: a changes in cardiac Ž . metabolism, b abnormal vascular sensitivity and reactiv-Ž . ity to various ligands, c increased stiffness of the ventricular wall associated with perivascular thickening of basement membrane and interstitial accumulation of glyco-Ž . protein and insoluble collagen, and d abnormalities of various proteins which control ion movements, specifically w x intracellular calcium 6 . Ž . Streptozotocin STZ induction of diabetes in rats is the most commonly used animal model of diabetes. The chemical structure of STZ comprises a glucose molecule with a highly reactive nitrosourea side-chain that is thought to initiate its cytotoxic action. The glucose moiety directs this w x agent to the pancreatic b-cell 8 . STZ selectively destroys pancreatic b-cells and produces a diabetic state, the sever-) Corresponding author. Tel. q1 604 822-9373; Fax q1 604 822-8001.
ity of which can be varied by altering the dose of STZ.
Ž . With time 4-6 weeks , rats so treated develop biochemical and functional myocardial abnormalities which are the result of the drug-induced metabolic changes rather than a w x direct effect of the drug itself 6 . Thus, rats made diabetic with STZ exhibit depressed left ventricular contractility, diminished ventricular compliance and decreased inotropic and chronotropic responses to certain drugs in isolated w x cardiac preparations 4,9,10 . Changes in contractile properties of the heart have also been found in vivo in both w x w x anaesthetised 11 and conscious 12,13 STZ-diabetic rats. Considering that the diabetic rat does not develop atherosclerosis, the in vivo and in vitro abnormalities in contractility and metabolism reflect changes in the function of the w x myocardial cell 14 . Hence, similar to the human condition, the STZ diabetic rat is a useful model to elucidate the pathogenesis of diabetic cardiomyopathy. In this review, Žw 2q x . evidence is presented that basal calcium Ca levels in i both quiescent and electrically-stimulated cardiac cells from STZ diabetic rats is unchanged and may not reflect the cardiac abnormalities observed in STZ diabetes. 
Intracellular Ca 2H in the diabetic heart
Evidence for abnormal myocardial cell function in diabetes mellitus, influenced by metabolic changes, has appeared in recent years. Experimental studies at the cellular level have provided data for several possible explanations for this cardiac dysfunction. Among these, an abnormal intracellular Ca 2q homeostasis and trans-sarcolemmal rew x ceptor signalling defects have been suggested 5,21 . For example, during chronic diabetes intracellular Ca 2q homeostasis in the heart is altered, possibly as a result of an impairment in SR which acts as a Ca 2q store and takes up 2q w x and releases Ca on a beat-to-beat basis 22 . Additionally, SL Ca 2q pump and Na-Ca exchange activity, together with the efflux of Ca 2q through the SL are dew x 2 q pressed in the diabetic heart 23,24 . Mitochondrial Ca abnormalities have also been reported in the chronically w x diabetic rat heart 5 . Among the receptor defects, cardiac b-adrenoceptor function is altered in diabetic animals. These alterations include a depressed b-receptor number, a reduced response to b-adrenergic agonists, and a significant alteration in the response and sensitivity to perfusate 2q w x Ca stimulation 10,25-27 . These results collectively support the hypothesis that diabetes mellitus leads to an alteration in Ca 2q movements in the heart. In more recent years, intracellular Ca 2q mobilization and contractility in the diabetic heart have been studied using isolated cardiomyocytes that have the responses of an intact heart but are not affected by non-myocardial w x tissues 28 . channels. This could explain the greater reduction of APD induced by Ca 2q blockers in ventricular myocardium of w x Ž . diabetic rats 48 . Delayed rectifier current I is involved K in the slower phase of action potential repolarization; decrease of this current in diabetic myocytes may contribute to the lengthening of the late repolarization phase w x of the action potential 46 . In a recent report, rate-dependent attenuation of I is more pronounced in cells from K w x diabetic rats 51 .
Na-Ca exchange actiÕity in SL of diabetic myocardium
Depressed Na-Ca exchange activity without change in affinity to Ca 2q has been previously reported in diabetic w x rats 24 . These changes may be due to compositional modifications in the SL membrane, possibly as a result of w x diabetes-induced hyperlipidemia 7 . In this regard, unpublished observations from our laboratory have indicated that the Na-Ca exchange in hypertensive-diabetic rats demonstrates a more significant increase in the affinity for Ca 2q . Interestingly, the hypertensive-diabetic rat model is known w x for its severe hyperlipidemia 7,52 .
SR Ca 2 q -ATPase in diabetic cardiomyocytes
It has been well documented that SR function in diabetic hearts is depressed. The early report of SR dysfunction in the diabetic rat heart came from isolated cardiac membrane vesicles whereby the uptake of 45 
Rapid-cooling and caffeine contractures
The Ca 2q content of the SR that is available for release is clearly an important determinant of the contractile state. Two approaches have been used to study SR Ca 2q in Ž . cardiomyocytes: rapid application of a cold solution Ž . Ž.
2 q RCC, ; 18C or b caffeine to induce SR Ca release. The resulting contracture can be used as an index of SR Ca 2q available for release. The advantage of using the above approaches is that they can be done 'on line' with w x contracted living cells 15 .
Rapid cooling of cardiac muscle results in a contracture that can be attributed to the quick release of SR Ca 2q to the cytoplasm. The amplitude of the contracture is indicative of the amount of Ca 2q available for release from SR at the time of cooling. During the cooling process, the probability of the SR Ca 2q release channel opening inw x w x creases 54 , the action potential duration is increased 55 , peak Ca 2q current decreases, myofilament Ca 2q sensitivw x ity is reduced 56 , and Na-Ca exchange activity is attenuw x w 2q x ated 56 . 
Mitochondrial function in diabetic hearts
The current view of Ca 2q accumulation by heart mitochondria is that it may act as a sink for Ca 2q under pathological conditions. Therefore, mitochondria may act as a potent and important buffering component of Ca 2q in the heart. A generalized depression of mitochondrial function exists in hearts from diabetic rats. Mitochondrial Ca-ATPase activity and Ca 2q transport capacity are significantly impaired in hearts from chronically diabetic rats w x 2q 58 . Although the alteration in Ca accumulation by mitochondria may have little effect on cardiac function on a beat-to-beat basis, any stimulus to the heart that results in w 2q x elevated Ca may not be adequately buffered in diai betic hearts. Direct measurement of mitochondrial calcium concentration in diabetic cardiomyocytes has not been made, although a technique for such a measurement is available and has been applied in other pathological modw x els such as anoxia and reoxygenation 59,60 . In a report using isolated cardiomyocytes, mitochondrial uptake of 45 Ca 2q , transmembrane potential gradient across the inner membrane of mitochondria, and cell respiration were significantly decreased in diabetic myocytes compared to w x control 61 . These changes were restored to normal by w x insulin treatment 61 .
Myofilaments and Ca 2 q sensitiÕity in diabetic cardiomyocytes
Two kinds of Ca 2q -dependent alterations may affect Ž . contractility of the diabetic heart: a changing the avail2q Ž . ability of Ca to the myofilaments, and b modifying the responsiveness of the myofilaments to activation by intracellular Ca 2q . The availability of intracellular Ca 2q is regulated by the SL and SR, and Ca 2q responsiveness is controlled by the myofilaments and the regulatory trow x ponin-tropomyosin complex 62 .
There has been no consistent finding regarding the sensitivity of the myofilament to Ca 2q . The sensitivity of w 2q x isolated myofibrils to Ca has been reported to be i w x w x unchanged 63 or increased 64 during diabetes. The increased sensitivity has been suggested to contribute to the slow time-course of relaxation. More recently, two studies have suggested that the sensitivity of myofilaments 2q w x to Ca was decreased during diabetes 65,66 . Although these experiments were performed under different conditions, the data appear to suggest that altered intracellular Ca 2q transients are not the only cause of cardiac dysfunction during diabetes.
It has been reported that the lower activity of myosin ATPase and abnormal myosin isoenzyme distribution could be responsible for the depressed contractile function in w x 2q diabetic myocardium 67 . Additionally, Ca -sensitivity of skinned diabetic myocytes is significantly enhanced w x with unchanged maximal activated tension 64 . In con- 
-sensitivity of myofilaments at pH 7.0, and decreased maximum tension-generating ability at pH w x 2q 6.6 in diabetes 66 . A decreased Ca -sensitivity of isometric tension in skinned cardiomyocytes from diabetic rats suggests that decreased cardiac output in the whole heart can occur independently of alterations in Ca 2q -handling by the SR or SL. During in vivo acidotic conditions such as ischemia and hypoxia, a substantial decrease in ventricular pressure may occur, in part due to changes in w x 2q myofilament protein expression 66 . The apparent Casensitivity was greatly diminished at a sarcomere length of Ž . 1.9 mm but was not affected at a longer length 2.4 mm . Another possibility is that diabetic Ca 2q -sensitivity changes in the myocardium are coupled with troponin T alterations w x 65 . 
Isoproterenol and 8-bromo-cAMP
In addition to the depressed response to isoproterenol, w 2q x diabetic myocytes also demonstrate an attenuated Ca i response to 8-bromo-cAMP at 10 y5 M and higher concenw x tration 32 . This suggests that at steps distal to the badrenoceptor and adenylate cyclase, diabetic myocytes exhibit a deficiency. Hence, there may be an alteration w 2q x between cAMP and Ca increase such as PKA activai tion and the phosphorylation of proteins. The phosphorylation process in the SR of diabetic myocytes is as yet unclear.
Ouabain
The response to ouabain in papillary muscle and left atria from hearts of diabetic rats was reported to be w x markedly depressed 69,70 . It was also reported that the maximum number of high-and low-affinity ouabain binding sites in membrane preparations obtained from chronically diabetic rats was significantly reduced to 60 and 49% of controls, respectively. These results suggest that the decreased inotropic response of ouabain in the intact cardiac tissue obtained from diabetic rats may be related to a w x decreased number of ouabain binding sites 71 . The altered K could be due to an alteration in the ouabain d binding sites or an altered composition of the membrane in diabetes. The activity of Na-K ATPase is dramatically w x reduced in the diabetic heart 72 . As this enzyme indiw 2q x rectly regulates Ca levels through its modulation of i w q x Na , the diabetes-linked decrease in Na-K ATPase aci tivity would be expected to mediate a net increase in both w q x w 2 q x Na and Ca . Myocardium from diabetic rats is i i 2 q Ž susceptible to Ca loading by ouabain incubation as . w x measured by afterdepolarizations 73 . These data suggest a decline in the reserve capacity of the sarcolemmal Na q pump in the diabetic heart. The decrease in Na-K ATPase could enhance the sensitivity to digitalis-like compounds by reducing the reserve capacity of the Na-pump and hence, the extent of digitalis-induced pump inhibition re-Ž quired before the onset of toxicity in the case of single . myocyte, hypercontraction . A reduction in reserve capacity may lower the tolerance to ouabain by decreasing the number of pump sites that the glycoside would have to w q x inhibit before eliciting a marked Na accumulation and i the resulting toxic effects believed to be mediated by Ca 2q -overload. Cardiac arrhythmias are a frequent and serious complication of the clinical use of digitalis glycosides, and it is possible that the tolerance to these cardiotoxic effects and the margin of safety for cardiotonic steroids is reduced in diabetic patients. 43 . This suggests that L-type Ca -channels are quantitatively and qualitatively altered in diabetes, and may be related to the nitrendipine effects found in this study. The effects of ATP in modulating Ca 2q -channel and intra2q w x cellular Ca store are very similar to KCl 74 . They are both sensitive to BAY K 8644, nifedipine, and EGTA and both are partially inhibited by ryanodine and caffeine. These similarities suggest that the ATP mechanism is w x similar to the KCl effects of membrane depolarization 74 and direct activation of Ca 2q -channels.
KCl and ATP

Summary
Ž
The quality control indices of myocyte isolation viabil-. ity, yield, survival time, cell response, etc. suggest that w 2q x the adult rat myocyte model is stable and useful in Ca i measurements and functional studies at the cellular level. Moreover, diabetic cardiomyocytes are a valuable model for studying cellular functions of the diabetic heart as they retain most of the features of cardiac dysfunction of intact w 2q x rat. Data from our studies indicate that the basal Ca in i both quiescent and electrically-stimulated cells is not w 2q x w 2 q x changed. Thus, resting levels of Ca and basal Ca i i transients may not reflect the abnormalities observed in diabetes until the system is challenged by certain stimuli. w 2q x Ca responses to isoproterenol are depressed in both i resting and stimulated diabetic cells. This suggests an alteration in the b-adrenergic pathway, possibly related to the b-adrenoceptor deficiency reported in the diabetic heart. SR Ca-ATPase is also involved in the isoproterenol-induced w 2q x Ca changes. Moreover, the decreased maximum rei sponse to 8-bromo-cAMP provides evidence of a post-receptor alteration in the pathway. Diabetic myocytes are more sensitive to ouabain, whereas the maximum response to ouabain was depressed. This may be the result of w q x depressed Na-K ATPase and increased Na . In diabetic myocytes, rapid cooling contractures and caffeine contractures are depressed, whereas caffeine-induced Ca 2q transients are decreased. Ryanodine binding suggests a decreased number of high-affinity binding sites in the SR of diabetic myocytes. Additionally, there are indications that SR releasable calcium is reduced and that the major functions of SR, notably uptake, release and storage, may be depressed in diabetic myocytes. Finally, L-type Ca 2q -channels are quantitatively and qualitatively altered in diabetes. Insulin treatment normalizes most of the diabetes-induced changes in cardiomyocytes, suggesting that metabolic alterations due to insulin deficiency play an important role in diabetic cardiomyopathy.
Results from several studies show that in diabetes the w 2q x function of major organelles which handle Ca in i myocytes is depressed, which in turn causes the alteration w 2q x of Ca mobilization in myocytes. Different second i messenger systems involved in E-C coupling may also be altered due to the metabolic impairments. The rapid increase in our understanding of the pathophysiology of calcium homeostasis in cardiomyocytes will be forthcoming as the powerful new tools of molecular and structural biology are used to investigate the regulation of the Ca 2q transport system. 
